- NCIt
- C35427
Loading cancer entity…
Loading cancer entity…
Clinical trials
10 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07819669 | Video-Assisted Thoracoscopic Surgery Combined With Radiofrequency Ablation Versus VATS Alone for Multiple Primary Lung Cancer | not yet recruiting | N/A | 160 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT06699979 | Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes | recruiting | — | 300 | Central South UniversityOTHER | 1 | Jul 7, 2026 |
| clinicaltrials |
| NCT03420963 | Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors | terminated | Phase 1 | 12 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT06973499 | Exploratory Study of the Microbiome of Upper Gastrointestinal in the Pathogenesis of Multiple Primary Lung Cancer | completed | — | 20 | Beijing Haidian HospitalOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT05662553 | ENB Guided MWA Combined With VATS Versus Sequential Surgery for Synchronous Bilateral Multiple Primary Lung Nodules | unknown | N/A | 172 | Ruijin HospitalOTHER | 1 | Jan 10, 2023 | clinicaltrials |
| NCT04982900 | Treatment of EGFR-TKI for Residual Lesions of Multiple Synchronous Ground-glass Opacities(TERMGGO) | unknown | Phase 2 | 138 | Ruijin HospitalOTHER | 1 | Oct 5, 2021 | clinicaltrials |
| NCT05053802 | Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical Trial(MAGIC) | recruiting | Phase 2 | 146 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 1 | Sep 23, 2021 | clinicaltrials |
| NCT04840758 | Stereotactic Ablation Radiotherapy Combined With Sintilimab in Early Inoperable Synchronous Multiple Primary Lung Cancer | unknown | Phase 1 / Phase 2 | 39 | The First Affiliated Hospital of Xiamen UniversityOTHER | 0 | Apr 12, 2021 | clinicaltrials |
| NCT04326751 | Evolution of Multiple Primary Lung Cancer (Evolution) | unknown | — | 20 | Peking University People's HospitalOTHER | 0 | Mar 30, 2020 | clinicaltrials |
| NCT04026841 | The Efficacy of PD-1 Antibody Sintilimab on Early-stage Multiple Primary Lung Cancer With Ground Glass Density. | unknown | Phase 2 | 36 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Aug 2, 2019 | clinicaltrials |
Data updated 15 days agoSource updated Sep 15, 2026source: clinicaltrials